35
TABLE4.2 WA
~CN
FACIUiS‘IO ~
“iU3UKlW’(
X’TISSWI
,
~137
initial
IXE(resn)KR
TO
DIFflXWf~ClX5(F~y_’/
Liver
Rd
C.E. D.E.b/
Radimuclide
& pried
‘
“INITIAL DAILYINTAKE(~/d)”
!urrkes
=
Like C. E.D.E
1.7
E*[
1.8
E-5
0-30 ywlr
3.7
E-4
3.8
E-5
3&70 year
2.2
E-4
2.4
E+
4.7
H
2.4
E-4
1.8
E+
5.3
E-4
1.8
E-6
9.2
E-4
5.0
E-3
3.6
E-5
1.1
E-2
3.6
E-5
5.6
R-4
3.0
B-3
2.2
E+
6.6
E-3
2.2
E+
1.3
E-3
1.9
E-3
1.0
E-8
2.4
E-2
4.2
E-3
0-30 year
3.9
E-2
5.7
E-2
3.1
E-7
7.3
E-1
1.3
E-1
3&70 year
5.1
E-2
1.4
E-2
4.1
E-7
9.6
E-1
1.7
E-1
Nmwnlf-wl
initial
year
1.3
E-3
0-30 year
3.9
E-2
E-6
7.3
E-1
1.3
E-1
year
mtcmnl+w
initial
year
CE30 year
30-70 per
mJ’mnm-239.-24o
initial year
!
I
I
Like plutmiuu
5.7
E-2
I
1.6
30-70 ~
~
me~
- f-
h IXS@-dday.
It is,SPCXI~lY.
W
m lE@B (1987) uhicb pvvides factors in Sv/Bq (= 3.8 x redpimcurie),
d
is mm.sten t
uith ICS@~tiats
(ICRFI.986, 1987) .~fwtors
aUwforthefractimof
~ABSl@K)
FPK14t&gut, its distri&tim
8mfmsiderce
timeinti
lxxiy, tbe
-i~
~
effe~
d
its zadiaticn
in the lxxly, md iti
rate of p@sical
~.
bj CXsmitted effective
&se equivalent (wlmle-body dose).
Other dcses are ccamitted &se
equivakats
(tissue&se).
The C.E.D.E. is~smof
tidcxwequivalents
till
tissues of
tbebody ofastardard
aan, eachueighted bytkm2risk resulting frmaunit&3etn
that
t~asmto
tirigkfrwn
aunit betotb
tile
body.
c1 E+ signifies:
x 1V5.